Results 141 to 150 of about 80,770 (310)

Shedding light on the environmental efficiency of the public light service: minimising light pollution through the global Malmquist–Luenberger index

International Transactions in Operational Research, EarlyView.
Abstract The search for evidence in public management and the implementation of good management by public bodies is becoming increasingly important, and the principles of effectiveness and efficiency should be reinforced. Therefore, this paper aims to analyse the change in efficiency in the provision of public lighting services by local governments ...
Pablo Povedano‐Fernández, Gemma Pérez‐López, José Luis Zafra‐Gómez   +2 more
wiley   +1 more source

KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis – Results from a three‐armed RCT

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In this RCT, KOH 5% demonstrated superior clinical success to diclofenac 3% and placebo at the end of treatment in patients with mild‐to‐moderate actinic keratosis and comparable long‐term efficacy to diclofenac. Its fast onset of efficacy and favourable tolerability make KOH a valuable treatment option in early‐stage actinic keratosis treatment ...
U. Reinhold, N. Leitz, R. Dominicus, E. L. Szabó, T. Dirschka, G. Popp, T. C. Fischer, N. Adamini, R. Ostendorf, M. Asefi, H. Durani, T. Hölting, U. Amann, F. Kreuziger, T. Assmann, H. Brüning, L. Freitag, K. Hoffmann, R. Gedschold   +18 more
wiley   +1 more source

Green credit policy and firm’s labor productivity: evidence from Chinese heavily-polluting enterprises

Frontiers in Environmental Science
Taking the “Green Credit Guidelines” (also known as “Green Credit Policy”, GCP) in 2012 as a quasi-natural experiment, this study adopts the panel datasets between 2010 and 2019 for Chinese manufacturing firms listed publicly to examine the effects of ...
Yong Lan, Shuangshuang Zhang, Ping Zhou, Hailing Li, Xuesong Dong   +4 more
doaj   +1 more source

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I. Silverberg, Kim A. Papp, Diamant Thaçi, Marjolein S. De Bruin‐Weller, Adam Reich, Ketty Peris, Kirk Barber, Ryszard Galus, Andrzej Kaszuba, Matthew Zirwas, Walter K. Nahm, Gretel Trullenque, Laura Maintz, Sady Alpizar, Sang Wook Son, Vivian Laquer, Linda Stein Gold, Soo Yeon Cheong, Anna Ryzhkova, Agnes Drahos, Liliana Ulianov, Christophe Piketty   +24 more
wiley   +1 more source

Perfect Way to Ace Exam With GCP-GC-REP Exam Dumps [2022]

, 2022
Genesys Cloud Certified Professional – Reporting and Analytics
openalex   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Multi-Cloud Federated Computing: Optimizing Cost, Performance, and Disaster Recovery Across AWS, Azure, and GCP [PDF]

, 2021
Subhasis Kundu
openalex   +1 more source

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat, Shawn G. Kwatra, Adam Reich, Serge Boulinguez, Athanasios Tsianakas, Maxwell Sauder, Sebastien Barbarot, Jacek C. Szepietowski, Curdin Conrad, Andrew E. Pink, Elke Weisshaar, Laurent Misery, Martin Metz, Vivian T. Laquer, Raja K. Sivamani, Gil Yosipovitch, Diamant Thaçi, Lone Skov, Xiaoxiao Chen, Aliene Noda, Zarif K. Jabbar‐Lopez, Christophe Piketty, Sonja Ständer   +22 more
wiley   +1 more source

Adverse Effects Associated With Spinal Versus General Anaesthesia for Hip and Knee Arthroplasties: Protocol for a Systematic Review [PDF]

Acta Anaesthesiol Scand
ABSTRACT Background Spinal and general anaesthesia are the most common anaesthetic methods for hip and knee arthroplasties. Differences in their effects on short‐ and long‐term postoperative outcomes, including mortality morbidity, and adverse events, remain uncertain.
Therkelsen A, Christensen H, Kjældgaard A, Godthaab C, Sillassen C, Lunn T, Hägi‐Pedersen D, Varnum C, Lindberg‐Larsen M, Thybo K, Jakobsen J, Mathiesen O.   +11 more
europepmc   +2 more sources

WorkbookAberdeenHydroponicsfor GCP roots.xls

, 2014
Amelia Henry
openalex   +1 more source